Stocks Buzz: Fifth Third Bancorp (NASDAQ:FITB), American Airlines (NASDAQ:AAL), Brooks Automation, Inc. (NASDAQ:BRKS), Credit Suisse Asset (NYSEMKT:CIK), Rally Software Development (NYSE:RALY)

Fifth Third Bancorp (NASDAQ:FITB) and Balance Innovations LLC announced a joint marketing agreement. Fifth Third Bank and retail cash office reconciliation solutions provider Balance Innovations have teamed to offer each company’s cash management and payments expertise to provide solutions that will deliver distinctive value across all segments of the retail market. Fifth Third Bancorp (NASDAQ:FITB) belongs to Financial sector. Its net profit margin is 43.00% … Continue reading Stocks Buzz: Fifth Third Bancorp (NASDAQ:FITB), American Airlines (NASDAQ:AAL), Brooks Automation, Inc. (NASDAQ:BRKS), Credit Suisse Asset (NYSEMKT:CIK), Rally Software Development (NYSE:RALY)

Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN

ProQR Therapeutics N.V. (NASDAQ:PRQR) announced today the closing of its initial public offering of 8,625,000 ordinary shares at a public offering price of $13.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,125,000 additional ordinary shares. The aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, will be approximately $102 … Continue reading Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN

Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Merck & Co. Inc. (NYSE:MRK) has been sued by Bristol-Myers Squibb Co (BMY) and Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) for patent infringement of Bristol-Myers’ novel PD-1 inhibitor, Optivo. Merck recently won the US Food and Drug Administration’s (FDA) approval for its own PD-1 drug, Keytruda. This made the company the first one to enter the US immunotherapy market, which is expected to reach $35 … Continue reading Investors Watch List : Merck & Co (NYSE:MRK), Activision Blizzard (NASDAQ:ATVI), Brooks Automation (NASDAQ:BRKS), Entergy Corporation (NYSE:ETR), CytRx Corporation (NASDAQ:CYTR)

Top Wall Street Stories : Brooks Automation (NASDAQ:BRKS), Fidelity National Information (NYSE:FIS), Halliburton (NYSE:HAL), Abercrombie & Fitch Co. (NYSE:ANF), Adobe (NASDAQ:ADBE)

Brooks Automation Inc. (NASDAQ:BRKS) Insider David Pietrantoni unloaded 2,500 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $11.07, for a total transaction of $27,675.00. Following the transaction, the insider now directly owns 78,486 shares of the company’s stock, valued at approximately $868,840. Brooks Automation, Inc. (NASDAQ:BRKS) belongs to Technology sector. … Continue reading Top Wall Street Stories : Brooks Automation (NASDAQ:BRKS), Fidelity National Information (NYSE:FIS), Halliburton (NYSE:HAL), Abercrombie & Fitch Co. (NYSE:ANF), Adobe (NASDAQ:ADBE)